Education
About Us
Working with TipRanks
Follow Us
Veru (VERU)
NASDAQ:VERU
Semaglutide, Enobosarm
Obesity, Muscle Loss
Phase II
Active Not Recruiting
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Feb 20, 2024
―
Sabizabulin, Exemestane Monotherapy, Exemestane Plus Everolimus, Or Selective Estrogen Receptor Modulator
Metastatic Breast Cancer
Phase II
Withdrawn
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Oct 01, 2021
―
Enobosarm & Abemaciclib Combo, Non-Steroidal Ai, Or Steroidal Ai (Exemestane With Or Without Everolimus) Or Fulvestrant
Metastatic Breast Cancer
Phase III
Terminated
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Sep 21, 2021
―
Sacituzumab Govitecan-Hziy, Sabizabulin, Sabizabulin/Sacituzumab Govitecan-Hziy Combo
Metastatic Triple Negative Breast Cancer
Phase II
Withdrawn
P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .
Aug 10, 2021
―
Exemestane, Enobosarm
Metastatic Breast Cancer
Phase III
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Apr 27, 2021
―
Veru-111
Sars-Cov Infection
Phase III
Completed
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
Apr 09, 2021
―
Veru-100
Advanced Prostate Adenocarcinoma
Phase I/II
Terminated
To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer
Apr 09, 2021
―
Veru-111, Enzalutamide, Abiraterone
Metastatic Castration-Resistant Prostate Cancer, Androgen Resistant Prostatic Cancer
Phase III
Terminated
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
Apr 09, 2021
―
Veru-111
Respiratory Distress Syndrome, Adult
Phase II
Completed
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
May 13, 2020
―
Veru-111
Metastatic Castration Resistant Prostate Cancer
Phase I/II
Terminated
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Nov 20, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Veru (VERU) have in its pipeline
VERU is currently developing the following drugs: Semaglutide, Enobosarm, Sabizabulin, Exemestane Monotherapy, Exemestane Plus Everolimus, Or Selective Estrogen Receptor Modulator, Enobosarm & Abemaciclib Combo, Non-Steroidal Ai, Or Steroidal Ai (Exemestane With Or Without Everolimus) Or Fulvestrant. These drug candidates are in various stages of clinical development as the company works toward FDA approval.